These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3102639

  • 1. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
    Yamamoto M, Kubota Y, Matsuura M, Homma JY.
    Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
    Homma JY, Tanimoto H.
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB.
    Hum Vaccin; 2007 Sep; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract] [Full Text] [Related]

  • 8. Responses of adult volunteers to a Pseudomonas aeruginosa exotoxoid-A vaccine.
    Lydick E, Mclean AA, Woodhour AF, Callahan LT.
    J Infect Dis; 1985 Feb; 151(2):375. PubMed ID: 3918128
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa.
    Homma JY, Abe C, Tanamoto K, Hirao Y, Morihara K, Tsuzuki H, Yanagawa R, Honda E, Aoi Y, Fujimoto Y, Goryo M, Imazeki N, Noda H, Goda A, Takeuchi S, Ishihara T.
    Jpn J Exp Med; 1978 Apr; 48(2):111-33. PubMed ID: 101698
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.
    Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K.
    J Med Microbiol; 1998 Apr; 47(4):295-301. PubMed ID: 9568994
    [Abstract] [Full Text] [Related]

  • 13. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
    Baltch AL, Franke M, Smith RP, Asperilla M, Griffin P, Michelsen P, Lutz F.
    Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810
    [Abstract] [Full Text] [Related]

  • 14. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ, Fürer E, Sadoff JC, Germanier R.
    Antibiot Chemother (1971); 1987 Nov; 39():249-55. PubMed ID: 3118786
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of elastase, protease and common antigen (OEP) from Pseudomonas aeruginosa on protection against burns in mice.
    Kawaharajo K, Homma JY.
    Jpn J Exp Med; 1977 Dec; 47(6):495-500. PubMed ID: 416253
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.
    Schaad UB, Lang AB, Wedgwood J, Ruedeberg A, Que JU, Fürer E, Cryz SJ.
    Lancet; 1991 Nov 16; 338(8777):1236-7. PubMed ID: 1682645
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
    Tanomand A, Farajnia S, Najar Peerayeh S, Majidi J.
    Iran Biomed J; 2013 Nov 16; 17(1):1-7. PubMed ID: 23279828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.